Shorter Door-To-Balloon ST-Elevation Myocardial Infarction Time: Should There Be a Minimum Limit?

Insights

Rapid treatment for ST-elevation myocardial infarction (STEMI) is vital. While door-to-balloon (DTB) time is a quality metric, excessively reducing DTB may not improve mortality and could lead to unnecessary interventions.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Health Services Research

Background:

  • ST-elevation myocardial infarction (STEMI) requires rapid reperfusion to minimize myocardial damage and mortality.
  • Door-to-balloon (DTB) time, the interval from patient arrival to percutaneous coronary intervention, is a key quality indicator for STEMI care.
  • Existing literature links longer DTB times to increased mortality.

Purpose of the Study:

  • To review the relationship between DTB time and mortality in STEMI patients.
  • To discuss the established guidelines for DTB time.
  • To explore the potential risks of reducing DTB time beyond current recommendations.

Main Methods:

  • Literature review of studies examining DTB time and mortality in STEMI.
  • Analysis of current clinical guidelines for DTB time.
  • Discussion of the implications of overly aggressive DTB time reduction.

Main Results:

  • Longer DTB times are associated with higher mortality rates in STEMI.
  • Current guidelines recommend a DTB time of less than 90 minutes.
  • Reducing DTB time beyond recommended thresholds has not demonstrated improved mortality and may increase risks.

Conclusions:

  • While timely reperfusion is critical in STEMI, excessively shortening DTB time may not further reduce mortality.
  • Potential harms of overly aggressive DTB reduction include unnecessary interventions and delayed diagnosis of alternative conditions.
  • Adherence to current DTB guidelines is recommended, balancing speed with appropriate patient evaluation.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
345
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
350